BLLN(BillionToOne, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|
| 营业收入 | $71.73M | $152.58M | $305.11M |
| 毛利润 | $17.31M | $80.92M | $208.46M |
| 营业利润 | −$69.50M | −$47.15M | $16.02M |
| 净利润 | −$82.68M | −$41.57M | $7.45M |
| 经营现金流 | −$53.67M | −$41.38M | $24.59M |
| 自由现金流 | −$59.85M | −$46.78M | $15.71M |
| 摊薄每股收益 | $-8.45 | $-4.12 | $0.14 |